CGTN: Why is China's economy holding steady? Jiangsu Province has the answer 6-03-2026, 11:32

The Metals Company Announces Second Quarter 2025 Corporate Update Conference Call for Thursday, August 14, 2025  7-08-2025, 19:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00